Literature DB >> 18695813

Accidents with biological material and immunization against hepatitis B among students from the health area.

Elucir Gir1, Jeniffer Caffer Netto, Silmara Elaine Malaguti, Silvia Rita Marin da Silva Canini, Miyeko Hayashida, Alcyone Artioli Machado.   

Abstract

Undergraduate students from the health area often handle piercing-cutting instruments in their academic activities, which exposes them to the risk of contracting infections. This study aimed to analyze accidents with biological material among these students. Out of 170 accidents registered, 83 (48.8%) occurred with Dentistry students, 69 (40.6%) with Medical students, 11 (6.5%) with Nursing students and in 06 (3.5%) of the cases there was no such information in the files. Most accidents, 106 (62.4%), occurred with students from private schools and 55 (32.3%) with those from public schools. Percutaneous accidents occurred in 133 (78.2%) exposures and there was immediate search for specialized health care in only 38 (21.3%) accidents. In 127 (74.7%) accidents, the immunization schedule against hepatitis B was complete. Therefore, schools need to offer courses and specific class subjects regarding biosafety measures, including aspects related to immunization, especially the vaccine against hepatitis B.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695813     DOI: 10.1590/s0104-11692008000300011

Source DB:  PubMed          Journal:  Rev Lat Am Enfermagem        ISSN: 0104-1169


  2 in total

1.  What is the perception of biological risk by undergraduate nursing students?

Authors:  M Carmen Moreno-Arroyo; Montserrat Puig-Llobet; Anna Falco-Pegueroles; Maria Teresa Lluch-Canut; Irma Casas García; Juan Roldán-Merino
Journal:  Rev Lat Am Enfermagem       Date:  2016-07-04

2.  Hepatitis B vaccination coverage and postvaccination serologic testing among medical students at a public university in Brazil.

Authors:  Eduardo Pernambuco de Souza; Marcelo de Souza Teixeira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jul-Aug       Impact factor: 1.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.